Search results
State of the Union: Thyroid, Parathyroid, and Endocrine Surgery in 2024
… to tell people exactly what endocrine surgery is. So, in general, we define endocrine surgery as professionals who … done with it. Are those interventional options all in-office procedures? Yes, exactly. We do it right here in our office as an outpatient. You walk home five minutes …
Last Modified:
Medication Compliance is Key in Evaluating Patients for CABG and PCI
… A recent study published in Circulation shows that patients who take their medication … fared better with fewer major adverse cardiac events in the years after surgery. This study utilized data collected in 2004 from eight community hospitals. Investigators … Medication Compliance is Key in Evaluating Patients for CABG and PCI …
Last Modified:
Naltrexone Implant a Powerful New Tool in the Fight Against Opioid Addiction
… two ways to medically treat someone addicted to opioids in the United States. One is to prescribe methadone, a … and relapse, Vivitrol does not protect against overdose. In 2019 alone, the CDC reported that 136 people died of … a type of implantable naltrexone that slowly dissolves in the body, continuously releasing an effective dose of the …
Last Modified:
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplant
… and comprehensive assessment of the vulnerabilities in the systems and process of LDLT care to reduce medical … of LDLT care. This project will address an important gap in the knowledge needed to achieve high quality and safe LDLT … and comprehensively identify areas of vulnerabilities in LDLT care that can result in medical errors, 2) design and …
Last Modified:
Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH
… Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects with Compensated Cirrhosis Secondary to … evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic … Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH …
Last Modified:
Advancements in Interventional Endocrinology Take Center Stage During Thyroid Cancer Month
… Dr. Jennifer H. Kuo discusses the latest advancements in thyroid disease treatments and break down what it means … Advancements in Interventional Endocrinology Take Center Stage During …
Last Modified:
A Study to Evaluate Chronic Hepatitis C Infection in Adult Liver Transplant Recipients
… and ABT-333 With or Without Ribavirin (RBV) in Adult Liver Transplant Recipients with Genotype 1 … A Study to Evaluate Chronic Hepatitis C Infection in Adult Liver Transplant Recipients …
Last Modified:
Prevention of Lymphedema in Breast Cancer Patients using Lymphatic-Venous Anastomosis
… Prevention of Lymphedema in Breast Cancer Patients using Lymphatic-Venous Anastomosis …
Last Modified:
Thank you for your interest in Columbia’s Data & Heart Surgery Report.
… Thank you for your interest in Columbia’s Data & Heart Surgery Report. …
Last Modified:
A Study of the Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors
… PK, pharmacodynamics, and immunogenicity of MEDI4736 in combination with tremelimumab, MEDI4736 monotherapy or tremelimumab monotherapy in subjects with metastatic or recurrent gastric or … A Study of the Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally …
Last Modified:
A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
… receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study. … Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection …
Last Modified:
A Phase 1, Open-label Study to Evaluate the Safety and Tolerability of MEDI0680 (AMP-514) in Combination with MEDI4736 in Subjects with Advanced Malignancies
… MEDI0680 (AMP-514) and MEDI4736 are when given together in subjects with advanced cancers. MEDI0680 (AMP-514) and … The information learned from this study may be helpful in further development of MEDI0680 (AMP-514) and MEDI4736 for … Evaluate the Safety and Tolerability of MEDI0680 (AMP-514) in Combination with MEDI4736 in Subjects with Advanced …
Last Modified:
The Rise of Early Onset Colon Cancer: More cases in young adults
… A recent study published in The Journal of the National Cancer Institute shows that the incidence of colorectal cancer (CRC) in the U.S. is declining rapidly overall but curiously … Columbia. “We are seeing fewer new cases of colon cancer in individuals over age 50, due in large part to screening …
Last Modified:
Surgeons Discuss the Critical Effects of Racial Disparity in Cancer Clinical Trials
… trials that led to government-approved cancer drugs in the last decade didn’t report on race. In studies that did report on race, black and Hispanic … they are not actually required to do so. (This is in contrast to studies funded by the National Institute of …
Last Modified:
Newly Identified Cellular Markers Improve Targets for Chemotherapy in Breast Cancer Patients
… New markers found in cancer-associated cells could make it easier for doctors … to treat breast cancer, results of a new study published in Cancer Cell suggest. These new types of identifiers will … have the opportunity to discover a new targeted therapy.” In this study , published in April 2019, the investigators …
Last Modified: